Assays Predict Non-responders to Advanced Prostate Cancer Therapies Assays Predict Non-responders to Advanced Prostate Cancer Therapies

Two circulating tumor cell (CTC) assays can predict which men with advanced prostate cancer are unlikely to benefit from anti-androgen therapies, researchers said in a June 4 presentation at ASCO 2018.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news